# Detection and Characterization of Thermotolerant Campylobacter Resistant to Antibiotics of Priority Use in Humans Present in Broiler Slaughterhouses and Retail Markets

**Authors:** Florencia Aylen Lencina, Carolina Raquel Olivero, Jorge Alberto Zimmermann, María Ángeles Stegmayer, Noelí Sirini, Laureano Sebastián Frizzo, Lorena Paola Soto, Marcelo Lisandro Signorini, María Virginia Zbrun

PMC · DOI: 10.3390/antibiotics15020158 · Antibiotics · 2026-02-02

## TL;DR

The study found antibiotic-resistant thermotolerant Campylobacter in poultry slaughterhouses and retail markets, highlighting a risk to public health due to multidrug resistance and virulence.

## Contribution

This study characterizes multidrug-resistant thermotolerant Campylobacter in poultry supply chains, identifying genetic mutations and virulence factors.

## Key findings

- Thermotolerant Campylobacter resistant to ciprofloxacin and erythromycin was detected in 48.55% of slaughterhouse samples.
- Most isolates were multidrug resistant and carried virulence genes like flaA, flhA, and cadF.

## Abstract

Background: This study aimed to assess the presence of thermotolerant Campylobacter resistant to ciprofloxacin and erythromycin in poultry slaughterhouses and retail markets, as well as to characterize their multidrug resistance profiles, genetic determinants, and clonal relationships. Methods: Samples were collected at slaughterhouses from cecal content (n = 270), neck skin (n = 270), and wastewater (n = 9), and at retail markets from breast skin (n = 241). Isolates were obtained from mCCDA agar supplemented with ciprofloxacin (2 μg/mL) and identified as C. jejuni or C. coli by PCR. The agar microdilution test was used to determine the minimum inhibitory concentration for ciprofloxacin and erythromycin, and other critical antibiotics. Point mutations in gyrA (Thr86Ile) and 23S rRNA (A2075G), virulence genes (flaA, flhA, cadF, and cdt), and clonal relationships were assessed by PCR and PFGE. Results: At the slaughterhouses, thermotolerant Campylobacter spp. resistant to erythromycin and ciprofloxacin were detected in 48.55% (107/549) of the samples, whereas 4.56% (11/241) of retail samples were positive. The Thr86Ile substitution in gyrA and the A2075G mutation in the 23S rRNA gene were detected in 92.97% and 89.84% of the isolates, respectively. Most isolates (>80%) were multidrug resistant and harbored key virulence genes (flaA, flhA, and cadF). C. jejuni exhibited the highest prevalence of cdt genes (76.19%). There was substantial genotypic diversity among isolates, with broad distribution across the sampled matrices and sites. Conclusions: These findings highlight the circulation of multidrug-resistant and potentially virulent thermotolerant Campylobacter spp. in the later stages of the poultry meat supply chain.

## Linked entities

- **Genes:** GYRA (DNA GYRASE A) [NCBI Gene 820238], 23S rRNA (23S ribosomal RNA) [NCBI Gene 2597968], flaA (flagellin A) [NCBI Gene 905631], flhA (flagellar biosynthesis protein FlhA) [NCBI Gene 881867], cadF (outer membrane fibronectin-binding protein) [NCBI Gene 905765], Iyd (Iodotyrosine deiodinase) [NCBI Gene 39242]
- **Chemicals:** ciprofloxacin (PubChem CID 2764), erythromycin (PubChem CID 12560)

## Full-text entities

- **Diseases:** peripheral neuropathies (MESH:D010523), bowel diseases (MESH:D015212), TC (MESH:D002169), enteritis (MESH:D004751), irritable bowel syndrome (MESH:D043183), CIP (MESH:C565467), infection (MESH:D007239), foodborne diarrheal disease (MESH:D005517), MDR (MESH:D018088), injury to (MESH:D014947), Guillain-Barre syndrome (MESH:D020275), Miller Fisher syndrome (MESH:D019846), AMR (MESH:D060467)
- **Chemicals:** Agarose (MESH:D012685), CO2 (MESH:D002245), AMP (MESH:D000249), Ampicillin (MESH:D000667), amphenicols (MESH:D002701), glycerol (MESH:D005990), penicillins (MESH:D010406), tetracycline (MESH:D013752), Bolton broth (-), quinolone (MESH:D015363), Fluoroquinolones (MESH:D024841), macrolide (MESH:D018942), tetracyclines (MESH:D013754), water (MESH:D014867), Erythromycin (MESH:D004917), gentamicin (MESH:D005839), aminoglycosides (MESH:D000617), saline (MESH:D012965), enrofloxacin (MESH:D000077422), Ciprofloxacin (MESH:D002939), agar (MESH:D000362), ethidium bromide (MESH:D004996)
- **Species:** Gallus gallus (bantam, species) [taxon 9031], Homo sapiens (human, species) [taxon 9606], Triactinomyxon sp. C (species) [taxon 182363], Campylobacter jejuni (species) [taxon 197], Ovis aries (domestic sheep, species) [taxon 9940], Campylobacter coli (species) [taxon 195]
- **Mutations:** T86I, A2075 G

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937461/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937461/full.md

## References

76 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937461/full.md

---
Source: https://tomesphere.com/paper/PMC12937461